Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Axsome (AXSM) Completes Patient Randomization in TRD Study
02:34pm, Thursday, 23'rd Jan 2020
Axsome (AXSM) closes patient randomization in the late-stage study of AXS-05 for addressing patients with treatment resistant depression.
Axsome (AXSM) Completes Patient Randomization in TRD Study
02:34pm, Thursday, 23'rd Jan 2020
Axsome (AXSM) closes patient randomization in the late-stage study of AXS-05 for addressing patients with treatment resistant depression.
The Cutting Edge Of Systematic Investing
05:48pm, Tuesday, 21'st Jan 2020
Systematic or Quantitative Investing continues to be a bigger part of the market as it delivers stronger market-beating returns fairly consistently. Experts oft
Biotech Bonanza: 2020 Outlook In An Election Year
09:15pm, Wednesday, 08'th Jan 2020
Biotechs closed out 2019 on a strong note, with the fourth quarter providing the longest sustained rally of the entire year. Favorable regulatory shifting, a ti
Market Action Is Quite Random
03:45pm, Tuesday, 31'st Dec 2019
The indices moved into positive territory and now the action has cooled off.
Axsome Therapeutics stock climbs to 34-month high | AlphaStreet
03:33pm, Monday, 18'th Mar 2019
After the slump on weak results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month high of $11.33 on Monday. Traders were positive on patient enrollment in M
